Parallel Advisors’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$562	Buy	28 +18	+180%	+$361	﹤0.01%	3267
2025 Q1	$197	Buy	10 +6	+150%	+$118	﹤0.01%	3368
2024 Q4	$90	Buy	+4	New	+$90	﹤0.01%	3422